IS4961A - Kristallað form 4-[5-metýl-3-fenýlísoxasól-4-ýl] bensensúlfonamíðs - Google Patents
Kristallað form 4-[5-metýl-3-fenýlísoxasól-4-ýl] bensensúlfonamíðsInfo
- Publication number
- IS4961A IS4961A IS4961A IS4961A IS4961A IS 4961 A IS4961 A IS 4961A IS 4961 A IS4961 A IS 4961A IS 4961 A IS4961 A IS 4961A IS 4961 A IS4961 A IS 4961A
- Authority
- IS
- Iceland
- Prior art keywords
- phenylisoxazol
- benzenesulfonamide
- methyl
- crystalline form
- crystalline
- Prior art date
Links
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/40—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs
- H01L23/4006—Mountings or securing means for detachable cooling or heating arrangements ; fixed by friction, plugs or springs with bolts or screws
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L23/00—Details of semiconductor or other solid state devices
- H01L23/34—Arrangements for cooling, heating, ventilating or temperature compensation ; Temperature sensing arrangements
- H01L23/42—Fillings or auxiliary members in containers or encapsulations selected or arranged to facilitate heating or cooling
- H01L23/427—Cooling by change of state, e.g. use of heat pipes
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
- H01L2924/00—Indexing scheme for arrangements or methods for connecting or disconnecting semiconductor or solid-state bodies as covered by H01L24/00
- H01L2924/0001—Technical content checked by a classifier
- H01L2924/0002—Not covered by any one of groups H01L24/00, H01L24/00 and H01L2224/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Power Engineering (AREA)
- Computer Hardware Design (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Liquid Crystal Substances (AREA)
- Heat Sensitive Colour Forming Recording (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2437896P | 1996-08-14 | 1996-08-14 | |
| PCT/US1997/015126 WO1998006708A1 (en) | 1996-08-14 | 1997-08-12 | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IS4961A true IS4961A (is) | 1999-01-29 |
| IS1989B IS1989B (is) | 2005-02-15 |
Family
ID=21820280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS4961A IS1989B (is) | 1996-08-14 | 1999-01-29 | Kristallað form 4-[5-metýl-3-fenýlísoxasól-4-ýl] bensensúlfonamíðs |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US6441014B2 (is) |
| EP (2) | EP1283203A1 (is) |
| JP (2) | JP3631763B2 (is) |
| KR (1) | KR100383148B1 (is) |
| CN (1) | CN1205193C (is) |
| AP (1) | AP1055A (is) |
| AR (1) | AR009244A1 (is) |
| AT (1) | ATE228117T1 (is) |
| AU (1) | AU722072B2 (is) |
| BG (1) | BG64259B1 (is) |
| BR (1) | BR9711151A (is) |
| CA (1) | CA2264104A1 (is) |
| CZ (1) | CZ297679B6 (is) |
| DE (1) | DE69717281T2 (is) |
| DK (1) | DK0920422T3 (is) |
| EA (2) | EA001472B1 (is) |
| EE (1) | EE04237B1 (is) |
| ES (1) | ES2188971T3 (is) |
| GE (1) | GEP20022636B (is) |
| HU (1) | HUP0400923A3 (is) |
| IL (2) | IL128255A (is) |
| IS (1) | IS1989B (is) |
| LT (1) | LT4551B (is) |
| LV (1) | LV12274B (is) |
| NO (1) | NO312461B1 (is) |
| NZ (1) | NZ334132A (is) |
| OA (1) | OA11298A (is) |
| PL (1) | PL191313B1 (is) |
| PT (1) | PT920422E (is) |
| RO (1) | RO120771B1 (is) |
| RS (1) | RS49671B (is) |
| SI (1) | SI9720059B (is) |
| SK (1) | SK283558B6 (is) |
| TR (1) | TR199900298T2 (is) |
| TW (1) | TW527350B (is) |
| UA (1) | UA52684C2 (is) |
| WO (1) | WO1998006708A1 (is) |
| ZA (1) | ZA977314B (is) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR9711151A (pt) * | 1996-08-14 | 1999-08-17 | Searle & Co | Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida |
| NZ333399A (en) * | 1997-12-24 | 2000-05-26 | Sankyo Co | Cyclooxygenase-2 inhibitors (COX-2) for the prevention and treatment of tumors, cachexia and tumor-metastasis |
| GB9810920D0 (en) * | 1998-05-21 | 1998-07-22 | Merck Sharp & Dohme | Therapeutic use |
| WO2000008001A1 (en) * | 1998-08-07 | 2000-02-17 | Chiron Corporation | Substituted isoxazole as estrogen receptor modulators |
| WO2000029022A1 (en) * | 1998-11-12 | 2000-05-25 | Algos Pharmaceutical Corporation | Cox-2 inhibitors in combination with centrally acting analgesics |
| JP2002538176A (ja) * | 1999-03-01 | 2002-11-12 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | トラマドール物質および選択的ｃｏｘ−２阻害薬を含んで成る組成物 |
| PL213323B1 (pl) * | 1999-08-20 | 2013-02-28 | Ortho Mcneil Pharm Inc | Kompozycja farmaceutyczna i jej zastosowanie |
| EP1212051A4 (en) * | 1999-08-27 | 2004-03-31 | Merck & Co Inc | METHOD OF TREATING OR PREVENTING CHRONIC PROSTATITIS OR CHRONIC PELVIC PAIN SYNDROME |
| JP2003523954A (ja) | 1999-12-08 | 2003-08-12 | ファルマシア コーポレイション | 治療効果が迅速に開始されるシクロオキシゲナーゼ−２阻害剤組成物 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| AR038957A1 (es) | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
| DK3168218T3 (en) * | 2001-08-15 | 2019-01-14 | Pharmacia & Upjohn Co Llc | Crystalline comprising an L-malic acid salt of N- [2- (DIETHYLAMINO) ETHYL] -5 - [(5-FLUOR-1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDE) METHYL] -2,4 -DIMETHYL-1H-PYRROL-3-CARBOXAMIDE FOR USE AS A MEDICINE |
| US20070072921A1 (en) * | 2002-07-26 | 2007-03-29 | Talley John J | Crystalline form of 4-[5-methyl-3-phenylisoxazol-4-yl] benzenesulfonamide |
| US7538126B2 (en) | 2003-04-04 | 2009-05-26 | Hetero Drugs Limited | Crystalline forms of valdecoxib |
| DK1534305T3 (da) | 2003-05-07 | 2007-02-05 | Osteologix As | Behandling af brusk-/knoglelidelser med vandoplöselige strontiumsalte |
| US20050182113A1 (en) * | 2003-12-30 | 2005-08-18 | Venkataraman Sundaram | Method for preparing diaryl-substituted isoxazole compounds |
| US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
| WO2005120499A1 (en) * | 2004-06-10 | 2005-12-22 | Chandiran Thakashinamoorthy | Form a of valdecoxib suitable for pharmaceutical formulations |
| MY147767A (en) | 2004-06-16 | 2013-01-31 | Janssen Pharmaceutica Nv | Novel sulfamate and sulfamide derivatives useful for the treatment of epilepsy and related disorders |
| DK1612203T3 (da) * | 2004-06-28 | 2007-12-03 | Gruenenthal Gmbh | Krystallinske former af (-)-(1R,2R)-3-(3-dimethylamino-1-ethyl-2-methylpropyl)-phenolhydrochlorid |
| KR100591786B1 (ko) | 2004-10-19 | 2006-06-26 | 휴먼팜 주식회사 | 프란루카스트를 함유하는 약학적 조성물 및 이의 제조 방법 |
| WO2006127184A1 (en) | 2005-05-20 | 2006-11-30 | Janssen Pharmaceutica N.V. | Process for preparation of sulfamide derivatives |
| US8716231B2 (en) | 2005-12-19 | 2014-05-06 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain |
| US8691867B2 (en) | 2005-12-19 | 2014-04-08 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| AR058389A1 (es) | 2005-12-19 | 2008-01-30 | Janssen Pharmaceutica Nv | Uso de derivados heterociclicos benzo-fusionados de sulfamida para el tratamiento de la obesidad |
| US8937096B2 (en) | 2005-12-19 | 2015-01-20 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocyle sulfamide derivatives for the treatment of mania and bipolar disorder |
| US8497298B2 (en) | 2005-12-19 | 2013-07-30 | Janssen Pharmaceutica Nv | Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| WO2007137167A2 (en) | 2006-05-19 | 2007-11-29 | Janssen Pharmaceutica N.V. | Co-therapy for the treatment of epilepsy |
| AU2009271362B2 (en) | 2008-06-23 | 2014-03-13 | Janssen Pharmaceutica Nv | Crystalline form of (2s)-(-)-N-(6-chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide |
| US8815939B2 (en) | 2008-07-22 | 2014-08-26 | Janssen Pharmaceutica Nv | Substituted sulfamide derivatives |
| CN103172583A (zh) * | 2013-03-07 | 2013-06-26 | 深圳市资福药业有限公司 | 一种制备帕瑞昔布的方法 |
| US10028904B2 (en) | 2014-12-04 | 2018-07-24 | Wisconsin Alumni Research Foundation | Transdermal cannabinoid formulations |
| US9375417B2 (en) | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
| CN114441666B (zh) * | 2020-11-05 | 2024-02-27 | 成都百裕制药股份有限公司 | 一种4-(5-甲基-3-苯基-4-异恶唑)苯磺酰氯中杂质的检测方法 |
| US20240165148A1 (en) | 2021-03-15 | 2024-05-23 | Saul Yedgar | Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
| EP0809636B1 (en) * | 1995-02-13 | 2002-09-04 | G.D. Searle & Co. | Substituted isoxazoles for the treatment of inflammation |
| US5633272A (en) | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| BR9711151A (pt) * | 1996-08-14 | 1999-08-17 | Searle & Co | Forma cristalina de 4-¬5-metil-3-fenilsoxazol-4-il¾benzenossulfonamida |
| US7538126B2 (en) * | 2003-04-04 | 2009-05-26 | Hetero Drugs Limited | Crystalline forms of valdecoxib |
| US20050272787A1 (en) * | 2004-05-19 | 2005-12-08 | Eswaraiah Sajja | Process for preparing crystalline form A of valdecoxib |
-
1997
- 1997-08-12 BR BR9711151A patent/BR9711151A/pt not_active Application Discontinuation
- 1997-08-12 WO PCT/US1997/015126 patent/WO1998006708A1/en active IP Right Grant
- 1997-08-12 SI SI9720059A patent/SI9720059B/sl not_active IP Right Cessation
- 1997-08-12 KR KR10-1999-7001263A patent/KR100383148B1/ko not_active Expired - Fee Related
- 1997-08-12 EA EA199900200A patent/EA001472B1/ru not_active IP Right Cessation
- 1997-08-12 CN CNB971985367A patent/CN1205193C/zh not_active Expired - Fee Related
- 1997-08-12 AT AT97938656T patent/ATE228117T1/de not_active IP Right Cessation
- 1997-08-12 EE EEP199900053A patent/EE04237B1/xx not_active IP Right Cessation
- 1997-08-12 EP EP02025507A patent/EP1283203A1/en not_active Withdrawn
- 1997-08-12 PL PL331607A patent/PL191313B1/pl not_active IP Right Cessation
- 1997-08-12 RO RO99-00176A patent/RO120771B1/ro unknown
- 1997-08-12 DE DE69717281T patent/DE69717281T2/de not_active Expired - Fee Related
- 1997-08-12 GE GEAP19974712A patent/GEP20022636B/en unknown
- 1997-08-12 CA CA002264104A patent/CA2264104A1/en not_active Abandoned
- 1997-08-12 SK SK136-99A patent/SK283558B6/sk not_active IP Right Cessation
- 1997-08-12 IL IL12825597A patent/IL128255A/en not_active IP Right Cessation
- 1997-08-12 IL IL16122497A patent/IL161224A0/xx unknown
- 1997-08-12 AU AU40936/97A patent/AU722072B2/en not_active Ceased
- 1997-08-12 AP APAP/P/1999/001458A patent/AP1055A/en active
- 1997-08-12 JP JP51012198A patent/JP3631763B2/ja not_active Expired - Fee Related
- 1997-08-12 CZ CZ0033499A patent/CZ297679B6/cs not_active IP Right Cessation
- 1997-08-12 ES ES97938656T patent/ES2188971T3/es not_active Expired - Lifetime
- 1997-08-12 DK DK97938656T patent/DK0920422T3/da active
- 1997-08-12 HU HU0400923A patent/HUP0400923A3/hu unknown
- 1997-08-12 EA EA200000891A patent/EA003754B1/ru not_active IP Right Cessation
- 1997-08-12 NZ NZ334132A patent/NZ334132A/en unknown
- 1997-08-12 EP EP97938656A patent/EP0920422B1/en not_active Expired - Lifetime
- 1997-08-12 PT PT97938656T patent/PT920422E/pt unknown
- 1997-08-12 TR TR1999/00298T patent/TR199900298T2/xx unknown
- 1997-08-14 AR ARP970103706A patent/AR009244A1/es not_active Application Discontinuation
- 1997-08-14 ZA ZA977314A patent/ZA977314B/xx unknown
- 1997-10-14 TW TW086111783A patent/TW527350B/zh not_active IP Right Cessation
- 1997-12-08 UA UA99031377A patent/UA52684C2/uk unknown
-
1999
- 1999-01-29 IS IS4961A patent/IS1989B/is unknown
- 1999-02-05 NO NO19990541A patent/NO312461B1/no unknown
- 1999-02-08 BG BG103155A patent/BG64259B1/bg unknown
- 1999-02-12 OA OA9900031A patent/OA11298A/en unknown
- 1999-02-12 RS YUP-74/99A patent/RS49671B/sr unknown
- 1999-03-05 LV LVP-99-40A patent/LV12274B/en unknown
- 1999-03-10 LT LT99-024A patent/LT4551B/lt active Protection Beyond IP Right Term
-
2000
- 2000-12-19 US US09/741,213 patent/US6441014B2/en not_active Expired - Fee Related
-
2002
- 2002-07-26 US US10/205,732 patent/US7135489B2/en not_active Expired - Fee Related
-
2004
- 2004-10-15 JP JP2004301644A patent/JP2005015497A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS1989B (is) | Kristallað form 4-[5-metýl-3-fenýlísoxasól-4-ýl] bensensúlfonamíðs | |
| EP1107735A4 (en) | FORMULATION OF OMEPRAZOLE | |
| NO986024D0 (no) | Substituerte 3,5-difenyl-1,2,4-triazoler og deres anvendelse som farmas÷yti | |
| ATE284385T1 (de) | Sulfonamidderivate | |
| DE69915704D1 (de) | Ampic dram | |
| DE69810179D1 (de) | Titannitridfilme | |
| PT1119430E (pt) | Fresa | |
| NO984290D0 (no) | Farmas°ytisk nyttige forbindelser | |
| DE59811308D1 (de) | Pufferspeicheranordnung | |
| DK0873308T3 (da) | O-Carbamoyl-phenylalaninol-forbindelser og deres farmaceutisk anvendelige salte | |
| EP0953464A4 (en) | LOUVRE | |
| DE69714228D1 (de) | Kristalline metallophosphate | |
| DE69907561D1 (de) | Titanatverbindungen | |
| DE69814590D1 (de) | Leistungsfreier hochgeschwindigkeitskonfigurationsspeicher | |
| DE59902712D1 (de) | Gefache | |
| KR970049232U (ko) | 못 파지장치 | |
| KR970058600U (ko) | 건축용 거푸집의 구조 | |
| KR970058599U (ko) | 건축용 거푸집 | |
| FI961195A0 (fi) | Briketterings- och krossningsmaskin foer plaster | |
| FI962848A0 (fi) | Vattenavstoetande mekaniskt haollfast gipsskiva | |
| FI960231L (fi) | Elementtipukki | |
| UA1371S (uk) | Цвях | |
| UA1372S (uk) | Цвях | |
| KR970052198U (ko) | 못 | |
| KR970049732U (ko) | 콘크리트 인서트 |